Drug Profile
Research programme: suprofenac - CIS Pharma
Alternative Names: diclofenac-prodrug; suprofenacLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator CIS Pharma
- Class
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Ocular inflammation; Pain
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Ocular-inflammation in Switzerland (Ophthalmic)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Pain in Switzerland (Transdermal)
- 17 Jul 2006 Preclinical trials in Ocular inflammation in Switzerland (Ophthalmic)